Overview

Study of Escitalopram in the Treatment of Specific Phobia

Status:
Completed
Trial end date:
2004-09-01
Target enrollment:
Participant gender:
Summary
This pilot study is designed to assess the efficacy of escitalopram in the treatment of specific phobia in adult outpatients.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Connor, Kathryn M., M.D.
Collaborator:
Forest Laboratories
Treatments:
Citalopram
Dexetimide